Luteinising hormone-releasing hormone antagonists in prostate cancer therapy.
about
Roles of prohibitin in growth control and tumor suppression in human cancersDrug transporter-independent liver cancer cell killing by a marine steroid methyl spongoate via apoptosis induction.Somatostatin and somatostatin receptors: implications for neoplastic growth and cancer biology.Bone microenvironment-targeted manipulations for the treatment of osteoblastic metastasis in castration-resistant prostate cancer.Cancer Treatment-Induced Bone Loss in Women With Breast Cancer and Men With Prostate Cancer.
P2860
Luteinising hormone-releasing hormone antagonists in prostate cancer therapy.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Luteinising hormone-releasing hormone antagonists in prostate cancer therapy.
@ast
Luteinising hormone-releasing hormone antagonists in prostate cancer therapy.
@en
Luteinising hormone-releasing hormone antagonists in prostate cancer therapy.
@nl
type
label
Luteinising hormone-releasing hormone antagonists in prostate cancer therapy.
@ast
Luteinising hormone-releasing hormone antagonists in prostate cancer therapy.
@en
Luteinising hormone-releasing hormone antagonists in prostate cancer therapy.
@nl
prefLabel
Luteinising hormone-releasing hormone antagonists in prostate cancer therapy.
@ast
Luteinising hormone-releasing hormone antagonists in prostate cancer therapy.
@en
Luteinising hormone-releasing hormone antagonists in prostate cancer therapy.
@nl
P2093
P2860
P1476
Luteinising hormone-releasing hormone antagonists in prostate cancer therapy.
@en
P2093
Evanthia Diamanti
Marinela Tzanela
Michael Koutsilieris
Pavlos Msaouel
P2860
P304
P356
10.1517/14728214.12.2.285
P407
P577
2007-05-01T00:00:00Z